Search results
The KDIGO 2024 CKD Guideline provides evidence-based recommendations for healthcare professionals, people with CKD and their caregivers, and policymakers. It covers topics such as CKD evaluation, risk assessment, medication management, and patient-centered care.
- KDIGO Announces Publication of 2024 CKD Guideline
Key highlights of the KDIGO CKD Guideline include guidance...
- Executive summary of the KDIGO 2024 Clinical Practice Guideline for the ...
The complete KDIGO 2024 Clinical Practice Guideline for the...
- KDIGO Announces Publication of 2024 CKD Guideline
13 mar 2024 · Key highlights of the KDIGO CKD Guideline include guidance updates on the measurements of estimated glomerular filtration rate and albuminuria, utilization of CKD risk prediction equations, and personalized treatment recommendations for kidney and cardiovascular risk reductions tailored to individual patient needs and preferences.
The KDIGO 2024 guideline updates the 2012 guideline and provides evidence-based recommendations for the evaluation and management of chronic kidney disease (CKD). It covers CKD across the lifespan, risk assessment, progression, complications, medication, and care models, and is based on systematic reviews and GRADE approach.
31 paź 2023 · This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the International Society of Nephrology or Elsevier.
S144 Summary of relative and absolute risks relevant to CKD from meta-analysis of large multinational population studies in the CKD Prognosis Consortium (CKD-PC)
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105 (4S):S117-S314. doi: 10.1016/j.kint.2023.10.018. Author. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Collaborators. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group:
The scope includes chapters dedicated to the evaluation and risk assessment of people with CKD, management to delay CKD progression and its complications, medication management and drug stewardship in CKD, and optimal models of CKD care.
